Propeller Health Receives FDA Clearance to Connect Patients Using the Symbicort® Inhaler to its Digital Health Platform May 26, 2020
Novartis receives CHMP positive opinion for Enerzair® Breezehaler® (QVM149), a potential first-in-class inhaled LABA/LAMA/ICS combination for uncontrolled asthma May 1, 2020
Express Scripts unveiled the first group of digital therapeutics included in its digital health formulary December 16, 2019
Asthma-related ER visits decline by more than half for patients using digitally connected inhalers December 11, 2018
